| Literature DB >> 23113022 |
Z Rahnavard1, S Eybpoosh, M Rezaei Homami, Hr Aghaei Meybodi, B Azemati, R Heshmat, B Larijani.
Abstract
BACKGROUND: The prevalence of vitamin D deficiency and its causative factors has been estimated more frequently in elder population, women, and patients with osteoporosis in different countries, but this issue is less defined in male population within different age groups especially in Asian countries. Therefore, we studied the role of effective factors in vitamin D deficiency and its prevalence in Iranian healthy men.Entities:
Keywords: Deficiency; Healthy male; Iran; Osteoporosis; Vitamin D
Year: 2010 PMID: 23113022 PMCID: PMC3481630
Source DB: PubMed Journal: Iran J Public Health ISSN: 2251-6085 Impact factor: 1.429
Descriptive and biochemical characteristics of the study population
|
| ||||||
|---|---|---|---|---|---|---|
| 43.45 (7.32) | 43.08 (14.68) | 47(12.12) | 46.9 (9.31) | 47.09 (15.08) | 2386 | |
| 175.01 (9.01) | 172.93 (7.32) | 173.76 (8.77) | 174.32 (5.66) | 172.80 (8.99) | 2202 | |
| 82.23 (9.88) | 73.35 (12.91) | 77.09 (12.32) | 71(10.02) | 73 (13.03) | 2200 | |
| 121.1 (12.30) | 123.15 (18.30) | 132.11 (15.81) | 127.14 (17.20) | 128.20 (15.20) | 1389 | |
| 70.66 (11.34) | 80.51 (10.12) | 80.62 (12.25) | 77.01 (18.62) | 92.04 (15.44) | 1388 | |
| 4.09 (0.68) | 4.3 (0.7) | 3.9 (0.4) | 4.7 (0.62) | 4.59 (0.71) | 2253 | |
| 3.30 (0.77) | 3.89 (0.61) | 3.31 (0.65) | 2.90 (0.8) | 4.51 (0.67) | 1763 | |
| 9.03 (1.11) | 9.38 (1.26) | 8.98 (1.34) | 9.08 (0.7) | 9.99 (1.41) | 2116 | |
| 54.09 (28.75) | 25.99 (19.06) | 43.37 (21.12) | 29.41 (18.77) | 31.84 (19.04) | 2113 | |
Lifestyle characteristics of the study population
| 0 | 155 (71.42) | 183 (61.20) | 161 (75.58) | 161(70.30) | 143 (72.58) | 803 (69.53) |
| 2 - 3 | 40 (18.43) | 81 (27.1) | 34 (15.96) | 45 (19.66) | 29 (14.73) | 229 (19.83) |
| > 3 | 22 (10.15) | 35 (11.70) | 18 (8.46) | 23 (10.04) | 25 (12.69) | 123 (10.64) |
| 217 (100) | 299 (100) | 213 (100) | 229 (100) | 197 (100) | 1155 (100) | |
| 0 | 49 (28.33) | 65 (33) | 37 (21.03) | 50 (29.25) | 49 (29.35) | 250 (28.28) |
| 0 - 15 | 15 (8.67) | 13 (6.60) | 15 (8.52) | 7 (4.09) | 14 (8.38) | 64 (7.25) |
| >15 | 109 (63) | 119 (60.40) | 124 (70.45) | 114 (66.66) | 104 (62.27) | 570 (64.47) |
| 173 (100) | 197 (100) | 176 (100) | 171 (100) | 167 (100) | 884 (100) | |
| None exposure | 49 (17.07) | 43 (16.28) | 52 (18.57) | 47 (17.93) | 56 (18.30) | 247 (17.66) |
| Just face & hands | 188 (65.51) | 180 (68.18) | 190 (67.86) | 179 (68.33) | 201 (65.68) | 938 (67.05) |
| More than face & hands | 50 (17.42) | 41 (15.54) | 38 (13.57) | 36 (13.74) | 49 (16.02) | 214 (15.29) |
| 287 (100) | 264 (100) | 280 (100) | 262 (100) | 306 (100) | 1399 (100) |
Prevalence of vitamin D deficiency in different subgroups
|
| |||||
|---|---|---|---|---|---|
| 2061 | 81 (3.9) | 807 (39.2) | 532 (25.8) | 641 (31.1) | |
| ≤ 19 | 4 | 0 (0) | 3 (75.0) | 1 (25.0) | 0 (0) |
| 20 – 29 | 468 | 13 (2.8) | 178 (38.0) | 143 (30.6) | 134 (28.6) |
| 30 – 39 | 413 | 21 (5) | 175 (42.4) | 104 (25.2) | 113 (27.4) |
| 40 – 49 | 415 | 18 (4.3) | 171 (41.2) | 105 (25.3) | 121 (29.20) |
| 50 – 59 | 393 | 13 (3.3) | 139 (35.4) | 100 (25.4) | 141 (35.9) |
| 60 – 69 | 334 | 16 (4.8) | 134 (40.1) | 73 (21.9) | 111 (33.2) |
| 70 – 79 | 33 | 0 (0) | 7 (21.2) | 6 (18.2) | 20 (60.6) |
| ≥ 80 | 1 | 0 (0) | 0 (0) | 0 (0) | 1 (100) |
| Tabriz | 582 | 22 (3.78) | 220 (37.8) | 172 (29.56) | 168 (28.86) |
| Tehran | 443 | 15 (3.38) | 266 (60.06) | 99 (22.34) | 63 (14.22) |
| Mashhad | 375 | 29 (7.73) | 152 (40.53) | 95 (25.33) | 99 (26.41) |
| Shiraz | 385 | 12 (3.1) | 130 (33.8) | 97 (25.2) | 146 (37.9) |
| Bushehr | 276 | 3 (1.1) | 39 (14.1) | 69 (25.1) | 165 (59.7) |
| 0 | 659 | 24 (3.64) | 315 (47.8) | 165 (25.04) | 155 (23.52) |
| 2 - 3 | 217 | 8 (3.6) | 74 (34.2) | 76 (35.02) | 59 (27.18) |
| > 3 | 117 | 4 (3.41) | 48 (41.02) | 38 (32.47) | 27 (23.07) |
| Total subjects | 993 | ||||
| 0 | 238 | 11 (4.62) | 99 (41.6) | 74 (31.1) | 54 (22.68) |
| <15 min | 653 | 14 (2.14) | 185 (28.34) | 172 (26.34) | 282 (43.18) |
| ≥15 min | 223 | 8 (3.6) | 124 (55.6) | 55 (24.66) | 36 (16.14) |
| Total subjects | 1114 | ||||
| 24.71 (3.7) | 25.2 (4.13) | 25.17 (4.33) | 25.4 (3.99) | ||
25 OHD level ≤ 12.5,
12.5 < 25 OHD level ≤ 25,
25 < 25 OHD level ≤ 35,
35.1 < 25 OHD level ≤ 150
- cut – off value units are ng/ml
Fig. 1:geographical variation in serum 25 OHD level